Eli Lilly vs. Novo Nordisk: The Weight Loss Drug Showdown

Eli Lilly’s latest weight loss drug has outperformed Novo Nordisk’s offerings, sparking a fierce competition in the obesity treatment market. This article explores the implications for both companies and the future of weight loss therapies.